BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10788503)

  • 1. Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line.
    Cox ME; Deeble PD; Bissonette EA; Parsons SJ
    J Biol Chem; 2000 May; 275(18):13812-8. PubMed ID: 10788503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
    Deeble PD; Murphy DJ; Parsons SJ; Cox ME
    Mol Cell Biol; 2001 Dec; 21(24):8471-82. PubMed ID: 11713282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
    Cox ME; Deeble PD; Lakhani S; Parsons SJ
    Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K.
    Gutiérrez-Cañas I; Juarranz MG; Collado B; Rodríguez-Henche N; Chiloeches A; Prieto JC; Carmena MJ
    Prostate; 2005 Apr; 63(1):44-55. PubMed ID: 15468165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
    Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.
    Kim J; Adam RM; Solomon KR; Freeman MR
    Endocrinology; 2004 Feb; 145(2):613-9. PubMed ID: 14563701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells.
    Zhang XQ; Kondrikov D; Yuan TC; Lin FF; Hansen J; Lin MF
    Oncogene; 2003 Oct; 22(43):6704-16. PubMed ID: 14555984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer.
    Wu C; Huang J
    J Biol Chem; 2007 Feb; 282(6):3571-83. PubMed ID: 17148458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.
    Deng X; Liu H; Huang J; Cheng L; Keller ET; Parsons SJ; Hu CD
    Cancer Res; 2008 Dec; 68(23):9663-70. PubMed ID: 19047143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells.
    Deeble PD; Cox ME; Frierson HF; Sikes RA; Palmer JB; Davidson RJ; Casarez EV; Amorino GP; Parsons SJ
    Cancer Res; 2007 Apr; 67(8):3663-72. PubMed ID: 17440078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine cells in prostate cancer.
    Amorino GP; Parsons SJ
    Crit Rev Eukaryot Gene Expr; 2004; 14(4):287-300. PubMed ID: 15663358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation.
    Kim J; Adam RM; Freeman MR
    Cancer Res; 2002 Mar; 62(5):1549-54. PubMed ID: 11888934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.
    Zelivianski S; Verni M; Moore C; Kondrikov D; Taylor R; Lin MF
    Biochim Biophys Acta; 2001 May; 1539(1-2):28-43. PubMed ID: 11389966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual effect of pituitary adenylate cyclase activating polypeptide on prostate tumor LNCaP cells: short- and long-term exposure affect proliferation and neuroendocrine differentiation.
    Farini D; Puglianiello A; Mammi C; Siracusa G; Moretti C
    Endocrinology; 2003 Apr; 144(4):1631-43. PubMed ID: 12639948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo.
    Burchardt T; Burchardt M; Chen MW; Cao Y; de la Taille A; Shabsigh A; Hayek O; Dorai T; Buttyan R
    J Urol; 1999 Nov; 162(5):1800-5. PubMed ID: 10524938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
    Yuan TC; Veeramani S; Lin MF
    Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
    Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase A-mediated phosphorylation of RhoA on serine 188 triggers the rapid induction of a neuroendocrine-like phenotype in prostate cancer epithelial cells.
    Jones SE; Palmer TM
    Cell Signal; 2012 Aug; 24(8):1504-14. PubMed ID: 22504159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
    Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
    Berenguer C; Boudouresque F; Dussert C; Daniel L; Muracciole X; Grino M; Rossi D; Mabrouk K; Figarella-Branger D; Martin PM; Ouafik L
    Oncogene; 2008 Jan; 27(4):506-18. PubMed ID: 17637748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.